跳至主要内容
临床试验/CTRI/2023/04/051559
CTRI/2023/04/051559尚未招募Unknown

Motivational Enhancement Therapy to Reduce Adverse TreatmentOutcomes (Default, Death and Failure)among TB Patients having Alcohol Abuseunder Programmatic Settings: a randomized control trial.

ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • NewTB patients having addiction of alcohol
  • Patients ready to give informedwrittenconsent

排除标准

  • New TB patients not having addiction of alcohol
  • TB Patients not ready to give informed written consent
  • TB patients less than 14/18 years of age i.e. pediatric age group will be
  • TB patients more than 65 years of age i.e. geriatric age group will be excluded.
  • TB patients having pre-identified complaints relating to mental retardation or
  • any other severe psychopathology.
  • TB patients having head injury or any severe neurological problem.
  • Multi-Drug Resistant TB patients
  • Pregnant women who have TB will be excluded.
  • Patients who do not take the full course of (12 sessions) of MET therapy would be excluded from the final analysis

研究者

发起方
ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases

相似试验